BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 11774402)

  • 1. Melan-A as a useful diagnostic immunohistochemical stain for the diagnosis of primary sinonasal melanomas.
    Snyder ML; Paulino AF
    Head Neck; 2002 Jan; 24(1):52-5. PubMed ID: 11774402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HMB-45 may be a more sensitive maker than S-100 or Melan-A for immunohistochemical diagnosis of primary oral and nasal mucosal melanomas.
    Yu CH; Chen HH; Liu CM; Jeng YM; Wang JT; Wang YP; Liu BY; Sun A; Chiang CP
    J Oral Pathol Med; 2005 Oct; 34(9):540-5. PubMed ID: 16138892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical diagnosis of malignant melanoma of the conjunctiva and uvea: comparison of the novel antibody against melan-A with S100 protein and HMB-45.
    Heegaard S; Jensen OA; Prause JU
    Melanoma Res; 2000 Aug; 10(4):350-4. PubMed ID: 10985669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of immunohistochemical staining of the novel antibody melan-A with S100 protein and HMB-45 in malignant melanoma and melanoma variants.
    Blessing K; Sanders DS; Grant JJ
    Histopathology; 1998 Feb; 32(2):139-46. PubMed ID: 9543670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HMB-45 and Melan-A are useful in the differential diagnosis between granular cell tumor and malignant melanoma.
    Gleason BC; Nascimento AF
    Am J Dermatopathol; 2007 Feb; 29(1):22-7. PubMed ID: 17284958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melan-A: not a helpful marker in distinction between melanoma in situ on sun-damaged skin and pigmented actinic keratosis.
    El Shabrawi-Caelen L; Kerl H; Cerroni L
    Am J Dermatopathol; 2004 Oct; 26(5):364-6. PubMed ID: 15365366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of Melan-A and Ki-67 in desmoplastic melanoma and desmoplastic nevi.
    Kucher C; Zhang PJ; Pasha T; Elenitsas R; Wu H; Ming ME; Elder DE; Xu X
    Am J Dermatopathol; 2004 Dec; 26(6):452-7. PubMed ID: 15618925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of melanocytic differentiation markers in malignant melanomas of the oral and sinonasal mucosa.
    Prasad ML; Jungbluth AA; Iversen K; Huvos AG; Busam KJ
    Am J Surg Pathol; 2001 Jun; 25(6):782-7. PubMed ID: 11395556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of melanoma antigens in epithelioid gastrointestinal stromal tumors: a potential diagnostic pitfall.
    Guler ML; Daniels JA; Abraham SC; Montgomery EA
    Arch Pathol Lab Med; 2008 Aug; 132(8):1302-6. PubMed ID: 18684030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can Melan-A replace S-100 and HMB-45 in the evaluation of sentinel lymph nodes from patients with malignant melanoma?
    Kucher C; Zhang PJ; Acs G; Roberts S; Xu X
    Appl Immunohistochem Mol Morphol; 2006 Sep; 14(3):324-7. PubMed ID: 16932024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Standard immunostains for melanoma in sentinel lymph node specimens: which ones are most useful?
    Karimipour DJ; Lowe L; Su L; Hamilton T; Sondak V; Johnson TM; Fullen D
    J Am Acad Dermatol; 2004 May; 50(5):759-64. PubMed ID: 15097961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microphthalmia transcription factor: not a sensitive or specific marker for the diagnosis of desmoplastic melanoma and spindle cell (non-desmoplastic) melanoma.
    Granter SR; Weilbaecher KN; Quigley C; Fletcher CD; Fisher DE
    Am J Dermatopathol; 2001 Jun; 23(3):185-9. PubMed ID: 11391097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of HMB-45 and anti-Melan A staining of sentinel lymph nodes with isolated positive cells.
    Mahmood MN; Lee MW; Linden MD; Nathanson SD; Hornyak TJ; Zarbo RJ
    Mod Pathol; 2002 Dec; 15(12):1288-93. PubMed ID: 12481009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HMB-45, S-100, NK1/C3, and MART-1 in metastatic melanoma.
    Zubovits J; Buzney E; Yu L; Duncan LM
    Hum Pathol; 2004 Feb; 35(2):217-23. PubMed ID: 14991540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melan-A/Mart-1 expression in various melanocytic lesions and in non-melanocytic soft tissue tumours.
    Orosz Z
    Histopathology; 1999 Jun; 34(6):517-25. PubMed ID: 10383696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical studies of conjunctival nevi and melanomas.
    Jakobiec FA; Bhat P; Colby KA
    Arch Ophthalmol; 2010 Feb; 128(2):174-83. PubMed ID: 20142539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of micrometastases in sentinel lymph nodes of cutaneous melanoma: higher diagnostic accuracy with Melan-A and MART-1 compared with S-100 protein and HMB-45.
    Shidham VB; Qi DY; Acker S; Kampalath B; Chang CC; George V; Komorowski R
    Am J Surg Pathol; 2001 Aug; 25(8):1039-46. PubMed ID: 11474288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is MAGE-1 expression in metastatic malignant melanomas really helpful?
    Gajjar NA; Cochran AJ; Binder SW
    Am J Surg Pathol; 2004 Jul; 28(7):883-8. PubMed ID: 15223957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of melan-A (MART1) in benign melanocytic nevi and primary cutaneous malignant melanoma.
    Busam KJ; Chen YT; Old LJ; Stockert E; Iversen K; Coplan KA; Rosai J; Barnhill RL; Jungbluth AA
    Am J Surg Pathol; 1998 Aug; 22(8):976-82. PubMed ID: 9706977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Marginal and joint distributions of S100, HMB-45, and Melan-A across a large series of cutaneous melanomas.
    Viray H; Bradley WR; Schalper KA; Rimm DL; Gould Rothberg BE
    Arch Pathol Lab Med; 2013 Aug; 137(8):1063-73. PubMed ID: 23899062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.